Related Experiment Video
Updated: Jul 4, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Molecular and bioinformatic analysis of apoptotic tumor suppressor genes in cervical cancer
Chetna Yadav1, Smiti Nanda2, Neelam Sehrawat1
1Department of Genetics, Maharshi Dayanand University, Rohtak, 124001, India.
Abstract:
This study aims to investigate the methylation status and mRNA expression of key apoptotic genes, including death-associated protein kinase (DAPK 1), tumor necrosis factor receptor superfamily member 6 (FAS), SMAC, and tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and its association with clinicopathological factors in cervical cancer cases. Methylation analysis was performed on 110 cervical cancer patients using qualitative methylation-specific polymerase chain reaction (MSP). Real-time PCR was used to analyze expression levels of selected genes. All samples were also analysed for the presence of high-risk HPV types (HPV 16 and 18) with specific primer. Additionally, association with clinicopathological and risk factors were evaluated. In-silico analysis was also done for further validation. The methylation status of DAPK, TRAIL R1, SMAC, and FAS was significantly different between cancer tissues and normal tissues. DAPK (0.001), FAS (0.001), and TRAIL R1 (0.02) were hypermethylated, and SMAC was found to be hypomethylated with the highest significance of < 0.0001. HPV 16 + samples were highly significant with DAPK (0.007) and FAS (0.013), and HPV 18 + samples were significant with DAPK (0.024), FAS (0.002) and TRAIL R1 (0.009). No HPV association was found with SMAC. Methylation was found to be inversely proportional to DAPK, TRAIL R1, and FAS expression. Aberrant promoter methylation of key apoptotic genes is significantly associated with cervical cancer and may contribute to its progression. Significant correlations with HPV infection and clinicopathological factors highlight their possible potential as predictive biomarkers. However, larger studies and functional validation are needed to confirm these findings and their clinical applicability.
Insights
Aberrant methylation of apoptotic genes like DAPK, FAS, and TRAIL-R1 is linked to cervical cancer progression. These gene alterations correlate with HPV infection and clinicopathological factors, suggesting potential as biomarkers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cervical cancer is a significant global health issue.
- Apoptosis plays a crucial role in cancer development and progression.
- Aberrant gene methylation is implicated in various cancers, including cervical cancer.
Purpose of the Study:
- To investigate the methylation status and mRNA expression of key apoptotic genes (DAPK, FAS, SMAC, TRAIL-R1) in cervical cancer.
- To explore the association between gene methylation, mRNA expression, and clinicopathological factors in cervical cancer.
- To evaluate the correlation with high-risk HPV types (16 and 18).
Main Methods:
- Methylation-specific polymerase chain reaction (MSP) on 110 cervical cancer patients.
- Real-time PCR for analyzing mRNA expression of selected apoptotic genes.
- HPV typing (HPV 16 and 18) and association analysis with clinicopathological factors.
- In-silico analysis for validation.
Main Results:
- Significant differences in methylation status of DAPK, TRAIL-R1, SMAC, and FAS between cancer and normal tissues.
- DAPK, FAS, and TRAIL-R1 were hypermethylated; SMAC was hypomethylated.
- HPV 16/18 infections showed significant associations with methylation of DAPK, FAS, and TRAIL-R1.
- Methylation was inversely correlated with DAPK, TRAIL-R1, and FAS expression.
Conclusions:
- Aberrant promoter methylation of key apoptotic genes is significantly associated with cervical cancer.
- These epigenetic alterations may contribute to cervical cancer progression.
- The findings suggest potential of these genes as predictive biomarkers, especially in conjunction with HPV infection and clinicopathological factors.
- Further research with larger cohorts and functional validation is warranted.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

